Cargando…
Racial/ethnic disparities on inflammation and response to methylprednisolone in severe COVID-19 pneumonia
BACKGROUND: Racial/ethnic minorities are at higher risk for severe COVID-19. This may be related to social determinants that lead to chronic inflammatory states. The aims of the study were to determine if there are racial/ethnic disparities with inflammatory markers and association of methylpredniso...
Autores principales: | Go, Ronaldo C., Nyirenda, Themba, Bojarian, Maryam, Hosseini, Davood K., Kim, Kevin, Rahim, Mehek, Paleoudis, Elli G., Go, Anna C., Han, Zhiyong, Sperber, Steven J., Gupta, Anjali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919360/ https://www.ncbi.nlm.nih.gov/pubmed/35287602 http://dx.doi.org/10.1186/s12879-022-07237-1 |
Ejemplares similares
-
Methylprednisolone, venous thromboembolism, and association with heparin to 30 days in hospital survival in severe Covid-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022) -
RACIAL/ETHNIC DISPARITIES ON INFLAMMATORY MARKERS IN SEVERE COVID-19 PNEUMONIA
por: GO, R., et al.
Publicado: (2022) -
Hydroxychloroquine, azithromycin and methylprednisolone and in hospital survival in severe COVID-19 pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2022) -
Methylprednisolone and 60 Days in Hospital Survival in Coronavirus Disease 2019 Pneumonia
por: Go, Ronaldo C., et al.
Publicado: (2021) -
Racial and Ethnic Trends and Disparities in NSCLC
por: Primm, Kristin M., et al.
Publicado: (2022)